A cheap pain reliever that can kill drug-resistant, tuberculosis-causing bacteria may never be tested.
The Scientist
Most Recent
This year’s prizes are awarded for advances in liver transplantation, cell biology, and leadership in biomedical science.
Doctors question whether a government initiative to speed approval for promising new drugs is ensuring safety.
A pair of mechanical leg braces that are controlled by their wearer’s brain signals could help paralyzed patients walk again.
Scientists hope an understanding of nerve fibers responsive only to gentle touch will give insight into the role the sense plays in social bonding.
Stem cells collected from younger donors are more effective for transplantation and regenerative medicine than those from older individuals.
The latest news from a long-term study of calorie restriction in rhesus macaques shows better health, but no boost in lifespan, in monkeys who eat less.
Results from a Phase II trial for cardiovascular disease with an epigenetic target therapy show promise.
A human trial of a hepatitis C treatment is shut down after one of the participants died.
Another person has died from the rodent-borne disease after visiting Yosemite National Park.
Follow The Scientist
Stay Connected with The Scientist
-
The Scientist Magazine
-
The Scientist Careers
-
Neuroscience Research Techniques
-
Genetic Research Techniques
-
Cell Culture Techniques
-
Microbiology and Immunology
-
Cancer Research and Technology
Current Issue
